Established digital pharmacy in prime Midtown Manhattan location offering a unique technology-enabled healthcare opportunity. This 5-year operational business has generated over $120 million in combined revenue since opening in 2022, with $35 million in annual revenue for 2025.

The business features comprehensive proprietary technology infrastructure including an employee workflow dashboard for payment processing and delivery dispatch, user-friendly patient app for prescription management and e-commerce, prescriber portal for seamless prescription transmission, and specialized delivery driver application with digital signature capabilities.

Key Business Metrics:
- Over 20,000 unique patient profiles
- 4,500+ active prescribing physicians
- High retention rates for both patients and prescribers
- Strong operational team in place
- Prime retail presence in high-traffic Manhattan location

The fully integrated technology platform streamlines operations from prescription receipt through final delivery, creating operational efficiency and enhanced patient experience. The business serves as an ideal acquisition target for experienced pharmacy operators seeking to expand their digital capabilities or telehealth companies requiring a proven distribution channel.

Growth opportunities include geographic expansion through the scalable business model and potential market penetration via strategic acquisitions. The established infrastructure and proven operational systems provide a foundation for rapid replication across multiple markets.

This turnkey operation combines traditional pharmacy services with cutting-edge technology, positioning it well within the growing digital healthcare sector. The business demonstrates strong financial performance with substantial revenue generation and maintains significant barriers to entry through its proprietary technology suite.

Will only speak to experienced operators of retail pharmacy or anyone with deep industry knowledge seeking immediate market presence and proven revenue streams. NDA and proof of funds needed.